Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 5
2015 4
2016 6
2017 8
2018 9
2019 9
2020 12
2021 7
2022 7
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening.
Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, Glaessgen A, Carlsson S, Grönberg H, Nordström T; STHLM3 consortium. Eklund M, et al. Among authors: discacciati a. N Engl J Med. 2021 Sep 2;385(10):908-920. doi: 10.1056/NEJMoa2100852. Epub 2021 Jul 9. N Engl J Med. 2021. PMID: 34237810 Clinical Trial.
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, Jäderling F, Eklund M, Grönberg H; STHLM3 study group. Nordström T, et al. Among authors: discacciati a. Lancet Oncol. 2021 Sep;22(9):1240-1249. doi: 10.1016/S1470-2045(21)00348-X. Epub 2021 Aug 13. Lancet Oncol. 2021. PMID: 34391509 Clinical Trial.
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality.
Björnebo L, Nordström T, Discacciati A, Palsdottir T, Aly M, Grönberg H, Eklund M, Lantz A. Björnebo L, et al. Among authors: discacciati a. JAMA Oncol. 2022 Jul 1;8(7):1019-1026. doi: 10.1001/jamaoncol.2022.1501. JAMA Oncol. 2022. PMID: 35587340 Free PMC article.
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women.
Hammarström M, Gabrielson M, Crippa A, Discacciati A, Eklund M, Lundholm C, Bäcklund M, Wengström Y, Borgquist S, Bergqvist J, Eriksson M, Tapia J, Czene K, Hall P. Hammarström M, et al. Among authors: discacciati a. Br J Cancer. 2023 Jul;129(1):61-71. doi: 10.1038/s41416-023-02293-z. Epub 2023 May 6. Br J Cancer. 2023. PMID: 37149701 Free PMC article. Clinical Trial.
Modeling the probability of occurrence of events.
Bottai M, Discacciati A, Santoni G. Bottai M, et al. Among authors: discacciati a. Stat Methods Med Res. 2021 Aug;30(8):1976-1987. doi: 10.1177/09622802211022403. Epub 2021 Jul 7. Stat Methods Med Res. 2021. PMID: 34232832 Clinical Trial.
One-stage dose-response meta-analysis for aggregated data.
Crippa A, Discacciati A, Bottai M, Spiegelman D, Orsini N. Crippa A, et al. Among authors: discacciati a. Stat Methods Med Res. 2019 May;28(5):1579-1596. doi: 10.1177/0962280218773122. Epub 2018 May 9. Stat Methods Med Res. 2019. PMID: 29742975
MRI-Targeted Biopsy in Prostate Cancer Screening. Reply.
Eklund M, Discacciati A, Nordström T. Eklund M, et al. Among authors: discacciati a. N Engl J Med. 2021 Nov 25;385(22):2110-2111. doi: 10.1056/NEJMc2115775. N Engl J Med. 2021. PMID: 34818498 No abstract available.
Predicting prolonged sick leave among trauma survivors.
von Oelreich E, Eriksson M, Brattström O, Discacciati A, Strömmer L, Oldner A, Larsson E. von Oelreich E, et al. Among authors: discacciati a. Sci Rep. 2019 Jan 11;9(1):58. doi: 10.1038/s41598-018-37289-w. Sci Rep. 2019. PMID: 30635611 Free PMC article.
63 results